Pharmacological treatment of young children with permanent junctional reciprocating tachycardia

Cardiology in the Young

Volumn 13, Issue 5, 2003, Pages 408-412

  van Stuijvenberg, Margriet ^a,b   Beaufort Krol, Gertie C M ^a   Haaksma, Jaap ^b   Bink Boelkens, Margreet Th E ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Arrhytmia; Catheter ablation; Drug treatment; Propafenone

Indexed keywords

DIGOXIN; PROPAFENONE; PROPRANOLOL; SOTALOL; VERAPAMIL; ANTIARRHYTHMIC AGENT;

ARTICLE; BRADYCARDIA; BRONCHOSPASM; CHILD CARE; CLINICAL ARTICLE; DRUG CHOICE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HEART FUNCTION; HEART LEFT VENTRICLE FAILURE; HEART RATE; HUMAN; INCIDENCE; INFANT; MALE; PR INTERVAL; QT PROLONGATION; SIDE EFFECT; SINUS RHYTHM; SUPRAVENTRICULAR TACHYCARDIA; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; WENCKEBACH PERIOD; DRUG COMBINATION; HEART LEFT VENTRICLE FUNCTION; NEWBORN; PAROXYSMAL TACHYCARDIA; RETROSPECTIVE STUDY; STATISTICAL MODEL;

ANTI-ARRHYTHMIA AGENTS; DIGOXIN; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; LOGISTIC MODELS; MALE; PROPAFENONE; RETROSPECTIVE STUDIES; TACHYCARDIA, PAROXYSMAL; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 2142715863     PISSN: 10479511     EISSN: 14671107     Source Type: Journal    
DOI: 10.1017/S1047951103000878     Document Type: Article

References (17)

1. Coumel P, Cabrol C, Fabiato A, Gourgon R, Slama R. Tachycardie permanente par rhythme reciproque. Arch Mal Coeur 1967; 60: 1830-1864.
2. Packer DL, Bardy GH, Worley SJ, et al. Tachycardia-induced cardiomyopathy: A reversible form of left ventricular dysfunction. Am J Cardiol 1986; 57: 563-570.
3. Kugler JD, Danford DA, Deal BJ, et al. Radiofrequency catheter ablation for tachyarrhythmias in children and adolescents. N Engl J Med 1994; 330: 1481-1487.
4. Goldberg CS, Caplan MJ, Heidelberger KP, Dick II M. The dimensions of the triangle of Koch in children. Am J Cardiol 1999; 83: 117-120.
5. Kugler JD, Danford DA, Houston K, Felix G. Radiofrequency catheter ablation for paroxysmal supraventricular tachycardia in children and adolescents without structural heart disease. Am J Cardiol 1997; 80: 1438-1443.
6. Blaufox AD, Felix GL, Saul JP. Radiofrequency catheter ablation in infants ≤ 18 months old. When is it done and how do they fare? Short-term data from the Pediatric Ablation Registry. Circulation 2001; 104: 2803-2808.
7. Saul JP, Hulse JE, Papagiannis J, Van Praag R, Walsh EP. Late enlargement of radiofrequency lesions in infant lambs: Implications for ablation procedures in small children. Circulation 1994; 90: 492-499.
8. Friedman RA, Walsh EP, Silka MJ, et al. NASPE Expert Consensus Conference: Radiofrequency Catheter Ablation in children with and without congenital heart disease. Report of the writing committee. PACE 2002; 25: 1000-1017.
9. Lindinger A, Heisel A, Von Bernuth G, et al. Permanent junctional re-entry tachycardia: A multicentre long-term follow-up study in infants, children and young adults. Eur Heart J 1998; 19: 936-942.
10. Fish FA, Gillette PC, Benson DW. Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. J Am Coll Cardiol 1991; 18: 356-365.
11. Dorostkar PC, Silka MJ, Morady F, Dick II M. Clinical course of persistent junctional reciprocating tachycardia. J Am Coll Cardiol 1999; 33: 366-375.
12. Critelli G. Recognizing and managing permanent junctional reciprocating tachycardia in the catheter ablation era. J Cardiovasc Electrophysiol 1997; 8: 226-236.
13. Aguinaga L, Primo J, Anguera I, et al. Long-term follow-up in patients with the permanent form of junctional reciprocating tachycardia treated with radiofrequency ablation. PACE 1998; 21: 2073-2078.
14. Drago F, Silvetti MS, Mazza A, et al. Permanent junctional reciprocating tachycardia in infants and children: Effectiveness of medical and non-medical treatment. Ital Heart J 2001; 2: 456-461.
15. Perry JC, McQuinn RL, Smith RT, Gothing C, Fredell P, Garson A. Flecainide acetate for resistant arrhythmias in the young: Efficacy and pharmacokinetics. J Am Coll Cardiol 1989; 14: 185-191.
16. Lucet V, Do Ngoc D, Sidi D, Batisse A, Fidelle J, Coumel P. Traitement medical et evolution a long terme des tachycardies reciproque permanentes de l'enfant à propos de 10 cas suivis durant 11 ans. Arch Mal Coeur 1985; 2: 210-216.
17. Janousek J, Paul T. Safety of oral propafenone in the treatment of arrhythmias in infants and children (European Retrospective Multicenter Study). Am J Cardiol 1998; 81: 1121-1124.